272 related articles for article (PubMed ID: 1981707)
1. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
[TBL] [Abstract][Full Text] [Related]
2. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
Pichard L; Fabre I; Daujat M; Domergue J; Joyeux H; Maurel P
Mol Pharmacol; 1992 Jun; 41(6):1047-55. PubMed ID: 1614409
[TBL] [Abstract][Full Text] [Related]
3. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P
Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily.
Combalbert J; Fabre I; Fabre G; Dalet I; Derancourt J; Cano JP; Maurel P
Drug Metab Dispos; 1989; 17(2):197-207. PubMed ID: 2565211
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes.
Bertault-Peres P; Bonfils C; Fabre G; Just S; Cano JP; Maurel P
Drug Metab Dispos; 1987; 15(3):391-8. PubMed ID: 2886317
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP
Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350
[TBL] [Abstract][Full Text] [Related]
7. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
9. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
Pichard L; Gillet G; Bonfils C; Domergue J; Thénot JP; Maurel P
Drug Metab Dispos; 1995 Nov; 23(11):1253-62. PubMed ID: 8591727
[TBL] [Abstract][Full Text] [Related]
10. Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125.
Vickers AE; Meyer E; Dannecker R; Keller B; Tynes RE; Maurer G
Drug Metab Dispos; 1995 Mar; 23(3):321-6. PubMed ID: 7628296
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
[TBL] [Abstract][Full Text] [Related]
12. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
Witkamp RF; Nijmeijer SM; Monshouwer M; Van Miert AS
Drug Metab Dispos; 1995 May; 23(5):542-7. PubMed ID: 7587928
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
[TBL] [Abstract][Full Text] [Related]
14. Oxidative metabolism of lansoprazole by human liver cytochromes P450.
Pichard L; Curi-Pedrosa R; Bonfils C; Jacqz-Aigrain E; Domergue J; Joyeux H; Cosme J; Guengerich FP; Maurel P
Mol Pharmacol; 1995 Feb; 47(2):410-8. PubMed ID: 7870052
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
Guengerich FP
Mol Pharmacol; 1988 May; 33(5):500-8. PubMed ID: 3285175
[TBL] [Abstract][Full Text] [Related]
16. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
Isoherranen N; Ludington SR; Givens RC; Lamba JK; Pusek SN; Dees EC; Blough DK; Iwanaga K; Hawke RL; Schuetz EG; Watkins PB; Thummel KE; Paine MF
Drug Metab Dispos; 2008 Jan; 36(1):146-54. PubMed ID: 17954524
[TBL] [Abstract][Full Text] [Related]
17. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.
Bornheim LM; Correia MA
Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes.
Kocarek TA; Schuetz EG; Strom SC; Fisher RA; Guzelian PS
Drug Metab Dispos; 1995 Mar; 23(3):415-21. PubMed ID: 7628309
[TBL] [Abstract][Full Text] [Related]
19. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
Augustine JA; Zemaitis MA
Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
[TBL] [Abstract][Full Text] [Related]
20. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
